PV Reporter

10:27 am

Pregnancy and Childbirth Outcomes in Women with MPNs

A Nationwide population-based study of 342 pregnancies in Sweden Abstract Pregnancy and childbirth in women with myeloproliferative neoplasms (MPN) are reported to be associated with maternal thrombosis, hemorrhage, and placental dysfunction. To assess the risks of adverse events in pregnancy in women with MPN, we performed a large population-based study using Swedish health care registers, […]

1:05 pm

MPN Awareness Day!

by David Wallace Today we celebrate MPN Awareness Day with our community! We are focused 24/7 on providing valuable resources to patients, caregivers and healthcare providers via our websites PV Reporter and MPN Cancer Connection. MPN Awareness and education is a daily practice rather than a special event. —> For myself personally, I take great […]

1:02 pm

Paving the way to improve therapy for MPNs

Megan Bywater & Steven W. Lane, Nature Communications volume 13, Article number: 5025, Published: August 26, 2022 Long-acting IFNα induces durable molecular responses in myeloproliferative neoplasms. Emerging studies, including Saleiro et al. recently published in Nature Communications, have identified promising candidates that may synergize with IFNα by targeting stem cell function or feedback loops that mediate […]

11:10 am

Treatments for ET and PV Moving Towards Disease Modification

by Christina T. Loguidice, OncLive Prevention and mitigation of cardiovascular events, such as thrombohemorrhagic complications, have been the main goal of treatment development for patients with essential thrombocythemia and polycythemia vera. Prevention and mitigation of cardiovascular events, such as thrombohemorrhagic complications, have been the main goal of treatment development for patients with essential thrombocythemia (ET) […]

7:40 am

Can Polycythemia Vera Patients Live a Normal Lifespan?

by David Wallace Transcript | Can Polycythemia Vera (PV) Patients Live a Normal Lifespan? David Wallace: So you had several important abstracts and one that our listeners with PV will be excited about. So tell us about the potential for normal life expectancy in PV. Dr. Abu-Zeinah: So this a project was inspired by our […]

Welcome to PV Reporter

PV Reporter was created to provide “easy access” to pertinent information on Polycythemia Vera (PV), Essential Thrombocythemia (ET) and Myelofibrosis (MF). These disorders are Myeloproliferative Neoplasms (MPNs), a closely related group of blood cancers where the bone marrow cells that produce the body’s blood cells function and develop abnormally.

If you are a newly diagnosed patient or researching MPNs, make PV Reporter your starting point. While many existing MPN websites provide excellent content, they tend to be internally focused or lack external search capabilities. PV Reporter solves that problem with MPN Search, a “custom search engine” retrieving exactly the information you are looking for!

Clinical Trial Finder

Free, No Personal Information Required

Search for MPN Clinical Trials that may help you find new treatments and medical approaches for your myelofibrosis (MF), polycythemia vera (PV) or essential thrombocythemia (ET).

ClinicalTrials.gov is difficult to use for patients, as it is primarily a resource for doctors and clinicians. Our Clinical Trial Finder restructures the trial information - providing "easy access" while improving patient's understanding of the trial.